(Q36642466)

15 August 2017

1 reference

title

Biochemistry and molecular biology of tauopathies (English)

1 reference

15 August 2017

0 references

Masato Hasegawa

1

1 reference

15 August 2017

1 October 2006

1 reference

15 August 2017

1 reference

15 August 2017

26

1 reference

15 August 2017

484-490

1 reference

15 August 2017

5

1 reference

The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

Structure and novel exons of the human tau gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

Genetic evidence for the involvement of tau in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1789.2006.00666.X

10.1111/J.1440-1789.2006.00666.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17080729